Pharmacokinetic features
Upon oral administration, Nifedipinum demonstrates high absorption of about 90%. However, the bioavailability is approximately 50% due to the first-pass metabolism in the liver.
- Onset of therapeutic effect: in 15–20 minutes.
- Achievement of maximum concentration ($C_{max}$): after 1–2 hours (in blood plasma — after 1–3 hours).
- Duration of action of the standard form: 6–8 hours.
- Half-life ($t_{1/2}$): 2–4 hours.
- Metabolism occurs in the liver, and elimination is carried out primarily by the kidneys.
Mechanism of antianginal action
The main difference between Nifedipinum and other dihydropyridines from other calcium channel blockers is that they have no direct effect on the heart muscle.
The therapeutic effect is realized exclusively at the level of the vascular bed:
- The effect on resistance vessels of the systemic circulation leads to a decrease in cardiac afterload.
- The effect on coronary vessels ensures improved oxygen delivery to the myocardium.
Indications and dosage forms
The drug is used in the therapy of the following pathologies:
- Vasospastic angina.
- Exertional angina.
- Arterial hypertension.
Features of the use of various forms:
- Short-acting forms are taken sublingually (under the tongue) with an onset of action in 15 minutes; their main purpose is the relief of hypertensive crises.
- Extended-release forms (retard) are taken orally 2 times a day and are intended for systematic course treatment of arterial hypertension.
Side effects
The use of the drug may be accompanied by the following adverse reactions:
- Excessive blood pressure drop (hypotension).
- Reflex tachycardia, occurring in response to systemic vasodilation.
- Peripheral ankle edema.
Briefly: answers to topical questions
What side effects does nifedipine cause?
Nifedipine causes a number of adverse reactions, mainly associated with its vasodilating effect. The main side effects of the drug include:
- Hypotension — excessive drop in blood pressure and mild orthostasis.
- Reflex tachycardia — a compensatory response to vasodilation.
- Peripheral edema — a specific symptom manifested by ankle edema.
- Neurological disorders — headache, dizziness, and fatigue.
- Other effects — hot flashes (facial flushing) and gingival hyperplasia.
What are the absolute contraindications to taking nifedipine?
Sources include the following among contraindications and limitations for nifedipine and other dihydropyridine calcium channel blockers:
- cardiogenic shock;
- severe aortic stenosis;
- obstructive cardiomyopathy;
- low blood pressure — with caution.
During pregnancy and the postpartum period, sublingual and intravenous administration of nifedipine are contraindicated. Short-acting forms should not be used for routine therapy.
Through which cytochrome P450 isoenzyme does the metabolism of nifedipine occur in the liver?
The metabolism of nifedipine (Nifedipinum) in the liver is carried out using the CYP3A4 isoenzyme. This enzyme belongs to the cytochrome P450 system and is the main isoform involved in the biotransformation of the largest number of drugs. Nifedipine acts as a substrate for CYP3A4, therefore its presystemic metabolism, bioavailability, and final concentration in the systemic circulation directly depend on the activity of this isoenzyme in hepatocytes and the intestinal wall.
With which drug groups does nifedipine have clinically significant interactions?
Nifedipine enters into clinically significant interactions with drugs that affect the activity of the CYP3A4 isoenzyme. The main groups include:
- CYP3A4 inhibitors — antifungals (azoles), macrolides, antiviral drugs (ritonavir), and nondihydropyridine calcium channel blockers. They slow down the metabolism of nifedipine, increasing the risk of toxic effects.
- CYP3A4 inducers — antiepileptics (carbamazepine, phenytoin, barbiturates), glucocorticoids, and antibiotics (rifampicin). They accelerate metabolism, reducing the concentration of the drug in the blood.
The interaction with furanocoumarins in grapefruit juice, which cause irreversible enzyme inhibition, is also significant.
Short-acting nifedipine under the tongue — the crisis disappeared at the same moment (action in 15 minutes).
Class and exam questions
Does nifedipine have a direct effect on the myocardium?
No. Unlike some other calcium channel blockers, dihydropyridine derivatives act exclusively on blood vessels, reducing afterload and dilating coronary arteries.
What is the main purpose of using sublingual drug forms?
Short-acting forms are used under the tongue for rapid relief of hypertensive crises due to the effect developing within 15 minutes.
Why are prolonged-release forms preferred in modern therapy?
Extended-release drugs provide more stable hemodynamics without sharp pulse surges and reflex reactions, and the rare dosing regimen increases patient adherence to treatment.
What else to study on this topic
- Classification of calcium channel blockers by chemical structure
- Comparative pharmacokinetics of short-acting and retard forms of dihydropyridines
- Pathogenesis of reflex tachycardia during vasodilator use
- Features of nifedipine metabolism in the liver
- Management tactics for patients with arterial hypertension and coronary artery disease
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Nifedipine" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Cardiovascular Drugs"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.